Article Details

Maxim Group Reiterates $18.00 Price Target for Coherus BioSciences (NASDAQ:CHRS)

Retrieved on: 2018-05-29 07:48:45

Tags for this article:

Click the tags to see associated articles and topics

Maxim Group Reiterates $18.00 Price Target for Coherus BioSciences (NASDAQ:CHRS). View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc bought a new position in Coherus BioSciences in the 1st quarter worth about $31,970,000. A.R.T. Advisors LLC bought a new ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up